To assess the iPA effect on the RhoA activity, we analyzed the level of the active GTP-bound form of RhoA by a pull-down assay with the Rho-binding fragment of rhotekin in GBM cells treated with iPA at 10 μM. This evidence concerns the gene RTKN and glioblastoma.